Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn more about Paige: https://www.paige.ai
| Website | http://paige.ai |
| Revenue | $29.4 million |
| Employees | 37 (15 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+45 more
(view full list)
|
| Industry | Software Development, Other Healthcare Technology Systems, Pathology, Laboratory Services (Healthcare), Artificial Intelligence, Machine Learning, Neural Networks, Computer Vision, Cancer, Healthcare, Computational Pathology |
| Keywords | Cancer Diagnostics, Artificial Intelligence, Healthcare Ai, Oncology, Cancer Research, Cancer Treatment, Digital Pathology, Pathology Informatics, Clinical Diagnostics, Medical Imaging, Precision Oncology, Machine Learning, Diagnostic Tools, Image Analysis, Cloud Based Platform, Data Analytics, Deep Learning, Biotechnology, Medical Technology, Healthcare It |
| Competitors | PathAI, Aiforia Technologies, Proscia, Tempus Labs, Inc., Freenome, Zebra Medical Vision Ltd, Viz.ai, Sema4, IBM, CureMetrix +33 more (view full list) |
Looking for a particular Paige employee's phone or email?
The Paige annual revenue was $29.4 million in 2026.
Razik Yousfi is the CEO and CTO of Paige.
15 people are employed at Paige.